milrinone and enoximone

milrinone has been researched along with enoximone in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	28 (50.91)	18.7374
1990's	18 (32.73)	18.2507
2000's	6 (10.91)	29.6817
2010's	3 (5.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barney, CL; Burkhard, T; Ertel, MA; Kariya, T; Kastner, PR; Marshall, FN; Matthews, DP; McCarthy, JR; Shea, PJ; Whitten, JP	1
Bobowski, G; Bristol, JA; Burke, SE; Evans, DB; Newton, RS; Sircar, I; Steffen, RP; Weishaar, RE	1
Bristol, JA; Humblet, CC; McPhail, AT; Moos, WH; Rithner, C; Sircar, I; Weishaar, RE	1
Bagli, J; Bogri, T; Lee, DK; McQuillan, J; Palameta, B; Peseckis, S; Rakhit, S	1
Alabaster, CT; Bell, AS; Campbell, SF; Ellis, P; Henderson, CG; Roberts, DA; Ruddock, KS; Samuels, GM; Stefaniak, MH	1
Bobowski, G; Bristol, JA; Duell, BL; Evans, DB; Sircar, I	1
Erhardt, PW	1
Alvarez, R; Bruno, JJ; Jones, GH; Venuti, MC	1
Hayes, JS; Kauffman, RF; Krushinski, JH; Pollock, GD; Robertson, DW; Wilson, H	1
Cantor, E; Chou, YL; Erhardt, PW; Hagedorn, AA; Ingebretsen, WR; Lampe, JW; Lumma, WC; Pang, D; Pease, CA; Wohl, RA	1
Bristol, JA; Evans, DB; Moos, WH; Sircar, I; Weishaar, RE	1
Topliss, JG; Yoshida, F	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
England, PJ; Murray, KJ	1
D'Aubioul, JA; de Chaffoy de Courcelles, DR; De Clerck, FF; Hermans, CF; Vandeplassche, GM; Wouters, LJ	1
Boldt, J; Hempelmann, G; Knothe, C	1
Fahrenkrog, U; Löllgen, H	1
Holmberg, SR; Williams, AJ	1
Lehot, JJ	1
Abdel-Aleem, S; Badr, M; Frangakis, C	1
Abdel-aleem, S; Frangakis, C	1
Drexler, H; Löllgen, H	1
Blinks, JR; Endoh, M; Taira, N; Yanagisawa, T	1
Braunwald, E; Colucci, WS; Wright, RF	1
Ahn, HS; Eardley, D; Prioli, N; Watkins, R	1
Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH	1
Baim, DS	2
Hood, WB	1
Hess, ML; Wood, MA	1
Janicki, JS; Maskin, CS; Weber, KT	1
Andersson, KE	1
Dhainaut, JF	1
Chiotti, D; Presbitero, P	1
Leier, CV	1
Chatterjee, K; Daly, PA; Kereiakes, D; Modin, G; Simonton, CA	1
Beavo, JA; Chang, ML; Harrison, SA	1
Tommaso, CL	1
Beavo, JA; Cadd, GG; Gallis, B; Harrison, SA; Reifsnyder, DH	1
Carlier, J; D'Orio, V; el Allaf, D	1
Arbogast, R	1
Lindeborg, DM; Pearl, RG	1
de Chaffoy de Courcelles, D; Roevens, P	1
Levy, JH; Salmenperä, M	1
Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R	1
Pfaffendorf, M; van Wezel, HB; van Zwieten, PA; Vroom, MB	1
Heintz, B; Kirsten, D; Kirsten, R; Nelson, K	1
Graf, BM; Grube, C; Martin, E; Stowe, DF; Zausig, YA; Zink, W	1
Calabrò, MG; Covello, RD; Greco, M; Greco, T; Landoni, G; Morelli, A; Pasin, L; Zangrillo, A	1
Bartsota, M; Bentley, S; Furck, AK; Rigby, ML; Slavik, Z	1
Beute, J; Boon, L; Braunstahl, GJ; de Bruijn, MJ; Ganesh, K; Hendriks, RW; Hockman, S; KleinJan, A; Koekoek, EP; Lambrecht, BN; Lukkes, M; Manganiello, VC; Nastiti, H; van Nimwegen, M	1

Reviews

18 review(s) available for milrinone and enoximone

Article	Year
In search of the digitalis replacement. Journal of medicinal chemistry, 1987, Volume: 30, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship	1987
Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents. Biochemical Society transactions, 1992, Volume: 20, Issue:2 Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Benzimidazoles; Dihydropyridines; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoenzymes; Milrinone; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Vasodilator Agents	1992
[Treatment with phosphodiesterase inhibitors: Pro]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1992, Volume: 27, Issue:5 Topics: Cardiac Output, Low; Enoximone; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones	1992
[Treatment with phosphodiesterase inhibitors: Contra]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1992, Volume: 27, Issue:5 Topics: Cardiac Output, Low; Enoximone; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones	1992
Use of inotropes in the critical care setting. Critical care medicine, 1990, Volume: 18, Issue:1 Pt 2 Topics: Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Epinephrine; Humans; Imidazoles; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stimulation, Chemical	1990
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. The New England journal of medicine, 1986, Feb-06, Volume: 314, Issue:6 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone	1986
The role of novel inotropic agents in the treatment of heart failure. Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 9 Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors	1986
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine. The American journal of cardiology, 1989, Jan-03, Volume: 63, Issue:2 Topics: Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones	1989
Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors. The American journal of the medical sciences, 1989, Volume: 297, Issue:2 Topics: Administration, Oral; Amrinone; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones	1989
Effects of new inotropic agents on exercise performance. Circulation, 1986, Volume: 73, Issue:3 Pt 2 Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Muscles; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Pyridones; Time Factors	1986
Some new positive inotropic agents. Acta medica Scandinavica. Supplementum, 1986, Volume: 707 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones	1986
[New inotropic drugs]. Cardiologia (Rome, Italy), 1988, Volume: 33, Issue:8 Topics: Adrenergic beta-Agonists; Amrinone; Cardiotonic Agents; Deoxyepinephrine; Enoximone; Ethanolamines; Heart; Humans; Imidazoles; Milrinone; Myocardial Contraction; Propanolamines; Pyridazines; Pyridones; Vasodilator Agents; Xamoterol	1988
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure. The American journal of medicine, 1986, Feb-28, Volume: 80, Issue:2B Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors	1986
The new inotropic phosphodiesterase inhibitors. Archives internationales de physiologie et de biochimie, 1984, Volume: 92, Issue:4 Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines	1984
[Effects of phosphodiesterase inhibitors on diastolic function]. Archives des maladies du coeur et des vaisseaux, 1993, Volume: 86 Spec No 2 Topics: Diastole; Enoximone; Heart Diseases; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones	1993
Inotropic therapy in the critically ill patient. International anesthesiology clinics, 1993,Spring, Volume: 31, Issue:2 Topics: Amrinone; Cardiac Glycosides; Cardiotonic Agents; Catecholamines; Critical Illness; Enoximone; Humans; Milrinone; Pyridones	1993
Clinical pharmacokinetics of vasodilators. Part II. Clinical pharmacokinetics, 1998, Volume: 35, Issue:1 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents	1998
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. British journal of anaesthesia, 2015, Volume: 114, Issue:5 Topics: Bayes Theorem; Cardiac Surgical Procedures; Critical Illness; Dobutamine; Enoximone; Humans; Hydrazones; Milrinone; Pyridazines; Simendan; Vasodilator Agents	2015

Trials

1 trial(s) available for milrinone and enoximone

Article	Year
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine. The American journal of cardiology, 1989, Jan-03, Volume: 63, Issue:2 Topics: Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones	1989

Other Studies

37 other study(ies) available for milrinone and enoximone

Article	Year
Synthesis and cardiotonic activity of novel biimidazoles. Journal of medicinal chemistry, 1990, Volume: 33, Issue:1 Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Chemical Phenomena; Chemistry; Dogs; Furans; Heart Rate; Imidazoles; Isoenzymes; Milrinone; Molecular Structure; Myocardial Contraction; Pyridones; Rats; Stimulation, Chemical; Structure-Activity Relationship; Thiazoles; Thiophenes	1990
Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for t Journal of medicinal chemistry, 1989, Volume: 32, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiotonic Agents; Dogs; Female; Fibrinolytic Agents; Heart Failure; Humans; Imidazoles; Male; Myocardial Contraction; Platelet Aggregation; Pyridazines; Structure-Activity Relationship; Vasodilator Agents	1989
Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity. Journal of medicinal chemistry, 1987, Volume: 30, Issue:11 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Myocardial Contraction; Spectrophotometry, Infrared; X-Ray Diffraction	1987
Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents. Journal of medicinal chemistry, 1988, Volume: 31, Issue:4 Topics: Animals; Blood Pressure; Cats; Dogs; Heart Rate; Models, Molecular; Myocardial Contraction; Pyrimidines; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Structure-Activity Relationship	1988
2(1H)-quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives. Journal of medicinal chemistry, 1988, Volume: 31, Issue:10 Topics: Animals; Dogs; Heart; Myocardial Contraction; Quinolones; Stimulation, Chemical; Structure-Activity Relationship	1988
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents. Journal of medicinal chemistry, 1985, Volume: 28, Issue:10 Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chemical Phenomena; Chemistry, Physical; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Pyridazines; Structure-Activity Relationship	1985
Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856). Journal of medicinal chemistry, 1987, Volume: 30, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Dogs; Humans; Imidazoles; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Myocardium; Quinazolines; Quinolines; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship	1987
Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones. Journal of medicinal chemistry, 1987, Volume: 30, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Chemical Phenomena; Chemistry; Dogs; Female; Indoles; Isoenzymes; Male; Myocardial Contraction; Myocardium; Pyridazines; Sarcoplasmic Reticulum; Spiro Compounds; Stimulation, Chemical; Structure-Activity Relationship	1987
Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents. Journal of medicinal chemistry, 1987, Volume: 30, Issue:8 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Ferrets; Heart Rate; Imidazoles; Myocardial Contraction; Papillary Muscles; Stimulation, Chemical; Structure-Activity Relationship	1987
Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure. Journal of medicinal chemistry, 1984, Volume: 27, Issue:9 Topics: Animals; Cardiotonic Agents; Dogs; Guinea Pigs; Heart Failure; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines	1984
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs. Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:5 Topics: Analysis of Variance; Animals; Cardiotonic Agents; Dogs; Enoximone; Female; Heart Ventricles; Hemodynamics; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Milrinone; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridones; Quinazolines	1992
Phosphodiesterase inhibitors and the cardiac sarcoplasmic reticulum calcium release channel: differential effects of milrinone and enoximone. Cardiovascular research, 1991, Volume: 25, Issue:7 Topics: Animals; Calcium Channels; Dose-Response Relationship, Drug; Enoximone; Imidazoles; In Vitro Techniques; Ion Channel Gating; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Ryanodine; Sarcoplasmic Reticulum; Sheep	1991
[New positive inotropic drugs]. Annales francaises d'anesthesie et de reanimation, 1991, Volume: 10, Issue:1 Topics: Adrenergic Agonists; Amrinone; Cardiotonic Agents; Dopamine; Enoximone; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Shock, Cardiogenic	1991
Stimulation of fatty acid oxidation in myocytes by phosphodiesterase inhibitors and adenosine analogues. Life sciences, 1991, Volume: 48, Issue:18 Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Amrinone; Animals; Cells, Cultured; Dipyridamole; Enoximone; Heart; Imidazoles; Milrinone; Myocardium; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Pyridones; Rats	1991
Stimulation of fatty acid oxidation by phosphodiesterase III inhibitors in rat myocytes. Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:2 Topics: Animals; Cells, Cultured; Enoximone; Heart; Imidazoles; Male; Milrinone; Muscle, Smooth, Vascular; Oxidation-Reduction; Palmitates; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Inbred Strains	1991
Enoximone and milrinone--inotropic vasodilators for severe heart failure. Drug and therapeutics bulletin, 1991, May-13, Volume: 29, Issue:10 Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Pyridones	1991
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation, 1986, Volume: 73, Issue:3 Pt 2 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Imidazoles; Male; Milrinone; Myocardial Contraction; Myocardium; Nifedipine; Nucleotides, Cyclic; Pyrazines; Pyridones; Quinolines; Time Factors	1986
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Biochemical pharmacology, 1986, Apr-01, Volume: 35, Issue:7 Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Colforsin; Cyclic AMP; Enoximone; Guinea Pigs; Hydrolysis; Imidazoles; Isoenzymes; Milrinone; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridones	1986
Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow. The American journal of cardiology, 1989, Jan-03, Volume: 63, Issue:2 Topics: Amrinone; Animals; Coronary Circulation; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones	1989
[Use of new inotropic agents in the treatment of acute cardiac failure]. Annales francaises d'anesthesie et de reanimation, 1988, Volume: 7, Issue:2 Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones	1988
General overview and update of positive inotropic therapy. The American journal of medicine, 1986, Oct-31, Volume: 81, Issue:4C Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors	1986
Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents. Chest, 1987, Volume: 92, Issue:1 Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Death, Sudden; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Milrinone; Pyridones; Quinazolines; Retrospective Studies; Time Factors	1987
Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs. Circulation, 1986, Volume: 73, Issue:3 Pt 2 Topics: Aminopyridines; Amrinone; Animals; Antibodies, Monoclonal; Cardiotonic Agents; Cattle; Cyclic GMP; Enoximone; Imidazoles; Isoenzymes; Mice; Milrinone; Myocardium; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Pyridones; Rabbits	1986
Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Molecular pharmacology, 1986, Volume: 29, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Amrinone; Animals; Antibodies, Monoclonal; Cardiotonic Agents; Cattle; Chromatography, DEAE-Cellulose; Chromatography, High Pressure Liquid; Cyclic GMP; Enoximone; Imidazoles; Immune Sera; Kinetics; Mice; Mice, Inbred BALB C; Milrinone; Molecular Weight; Myocardium; Phosphodiesterase Inhibitors; Phosphorylation; Pyridones	1986
Effects of amrinone on myocardial energetics in severe congestive heart failure. The American journal of cardiology, 1985, Jul-22, Volume: 56, Issue:3 Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Enoximone; Heart; Heart Failure; Humans; Imidazoles; Isoproterenol; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones	1985
Cyclic AMP-phosphodiesterase IIIA1 inhibitors decrease cytosolic Ca2+ concentration and increase the Ca2+ content of intracellular storage sites in human platelets. Biochemical pharmacology, 1993, Jun-09, Volume: 45, Issue:11 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminoquinolines; Blood Platelets; Calcium; Chlortetracycline; Cytosol; Enoximone; Heart; Homeostasis; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Quinazolines	1993
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. Anesthesia and analgesia, 1996, Volume: 82, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents	1996
Mechanism of action of OPC-8490 in human ventricular myocardium. Circulation, 1996, Feb-15, Volume: 93, Issue:4 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine	1996
Effect of phosphodiesterase inhibitors on human arteries in vitro. British journal of anaesthesia, 1996, Volume: 76, Issue:1 Topics: Adolescent; Adult; Amrinone; Analgesics; Anilides; Arginine; Arteries; Dipyridamole; Enoximone; Female; Glyburide; Humans; In Vitro Techniques; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Theophylline; Vasoconstriction; Vasodilation	1996
A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. Anesthesia and analgesia, 2006, Volume: 102, Issue:6 Topics: Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dose-Response Relationship, Drug; Enoximone; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Vasodilation	2006
Oral Enoximone as an Alternative to Protracted Intravenous Medication in Severe Pediatric Myocardial Failure. Pediatric cardiology, 2016, Volume: 37, Issue:7 Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Child; Enoximone; Heart Failure; Hemodynamics; Humans; Milrinone; Ventricular Dysfunction, Left	2016
A pathophysiological role of PDE3 in allergic airway inflammation. JCI insight, 2018, 01-25, Volume: 3, Issue:2 Topics: Allergens; Animals; Asthma; Biopsy; CD11b Antigen; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Enoximone; Eosinophils; Humans; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Milrinone; Off-Label Use; Phosphodiesterase 3 Inhibitors; Primary Cell Culture; Pyroglyphidae; Up-Regulation	2018